2025 -  WEEK 12

What's New in RWE Research this Week

  1. Bridging gaps in pediatric device development: The power of ACTION - a collaborative learning network. Mokshagundam D, Rosenthal DN, Smyth L, Lorts A. J Heart Lung Transplant. 2025 Apr;44(4):541-544. doi: 10.1016/j.healun.2024.12.018. PMID: 40113348 Review.

 

  1. Long-term mortality impact of postoperative hyperactive delirium in older hip fracture surgery patients. Sun M, Chen WM, Wu SY, Zhang J. BMC Geriatr. 2025 Mar 15;25(1):180. doi: 10.1186/s12877-025-05817-9. PMID: 40089713 Free PMC article.

 

  1. Real-world evidence: state-of-the-art and future perspectives. Fitzke H, Fayzan T, Watkins J, Galimov E, Pierce BF. J Comp Eff Res. 2025 Apr;14(4):e240130. doi: 10.57264/cer-2024-0130. Epub 2025 Mar 7. PMID: 40051332 Review.

 

  1. Planning Post-Launch Evidence Generation: Lessons From France, England and Spain. Kent S, Meyer F, Pavel A, Saborido CM, Austin C, Williamson S, Ray J, Facey K. Clin Pharmacol Ther. 2025 Apr;117(4):961-966. doi: 10.1002/cpt.3586. Epub 2025 Feb 17. PMID: 39960266 Free PMC article.

 

  1. Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective. Chen J, Gruber S, Lee H, Chu H, Lee S, Tian H, Wang Y, He W, Jemielita T, Song Y, Tamura R, Tian L, Zhao Y, Chen Y, van der Laan M, Nie L. Clin Pharmacol Ther. 2025 Apr;117(4):946-960. doi: 10.1002/cpt.3576. Epub 2025 Feb 14. PMID: 39949314 Review.

 

  1. Utilizing machine learning to identify fall predictors in India's aging population: findings from the LASI. Bharadwaz MP, Kalita J, Mitro A, Aditi A. BMC Geriatr. 2025 Mar 17;25(1):181. doi: 10.1186/s12877-025-05813-z. PMID: 40097950 Free PMC article.

 

  1. Long-term follow-up after authorization of gene therapy: leveraging real-world data. de Haart K, Asao K, Ataher Q, Geier J, Hillen J, Huang K, Mol PGM, Rivera D, Wang H, Yang H, Zhan S, Hoogendoorn WE, Bloem LT.Drug Discov Today. 2025 Mar 19:104337. doi: 10.1016/j.drudis.2025.104337. Online ahead of print.PMID: 40118445 Review.

 

  1. Public Disclosure of Results From Artificial Intelligence/Machine Learning Research in Health Care: Comprehensive Analysis of ClinicalTrials.gov, PubMed, and Scopus Data (2010-2023). Maru S, Kuwatsuru R, Matthias MD, Simpson RJ Jr.J Med Internet Res. 2025 Mar 21;27:e60148. doi: 10.2196/60148.PMID: 40117574

 

  1. FRONTIER: FReeStyle Libre system use in Ontario among people with diabetes in the IC/ES database-Evidence from real-world practice: Patients on basal insulin, glucagon-like peptide 1 receptor agonist or oral therapies. Ratzki-Leewing A, Harris SB, Rabasa-Lhoret R, Poon Y. Diabetes Obes Metab. 2025 Mar 21. doi: 10.1111/dom.16266. Online ahead of print.PMID: 40117297

 

  1. Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective. Uteh CO, Johnson EE, Robinson T, Moradi N, Inskip A, Beyer FR, Thomson K, Sagoo GS. 2025 Mar 21. doi: 10.1007/s40273-025-01480-5. Online ahead of print.PMID: 40117115 No abstract available.

 

  1. Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria. Trombadori C, Boccia E, Tran EH, Franco A, Orlandi A, Franceschini G, Carbognin L, Di Leone A, Masiello V, Marazzi F, Palazzo A, Paris I, Dattoli R, Mulè A, Capocchiano ND, Giannarelli D, Masetti R, Belli P, Boldrini L, D'Angelo A, Fabi A.Radiol Med. 2025 Mar 21. doi: 10.1007/s11547-025-01984-2. Online ahead of print.PMID: 40117102

 

  1. Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data. Nyholm D, Eggington S, Holm A.Neurol Ther. 2025 Mar 21. doi: 10.1007/s40120-025-00730-0. Online ahead of print.PMID: 40117084

 

  1. The Atrial FibriLlatiOn Registry (FLOW-AF): Patient Characteristics, Treatment Patterns, and Outcomes in Egypt. Sobhy M, Abdelhamid M, El Etriby AM, Gamaleldin MFS, Youssef AMH, Khalife N, Ragy H, Reda A, Sobhy M, Nawar M.Cardiol Ther. 2025 Mar 21. doi: 10.1007/s40119-025-00400-0. Online ahead of print.PMID: 40117063

 

  1. Physical Activity in Adults with Severe Asthma On-Treatment with Biological Therapies: A 1-Year Retrospective Analysis of Real-World Data. Reilly C, Stavropoulos-Kalinoglou A, Peckham D, Clifton IJ, Price OJ.Pulm Ther. 2025 Mar 20. doi: 10.1007/s41030-025-00292-4. Online ahead of print.PMID: 40113642

 

  1. Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan. Tamura A, Shimizu H, Fujii T, Kawamoto A, Morikawa R, Hibiya S, Takenaka K, Nagahori M, Ohtsuka K, Okamoto R.Intest Res. 2025 Mar 20. doi: 10.5217/ir.2024.00187. Online ahead of print.PMID: 40112856 Free article.

 

  1. Developing and Implementing Provider-Training and Evidence-Based Tools to Support Pre-exposure Prophylaxis (PrEP) Decision-Making and Increase PrEP Adherence Among Young Men Who Have Sex With Men: Protocol for the PrEP Choice Longitudinal Cohort Study. Rainer C, Schnall R, Tanner MR, Galindo CA, Hoover KW, Naar S, Brin M, Martinez A, Jia H, Mendoza M, Hightow-Weidman L.JMIR Res Protoc. 2025 Mar 20;14:e64186. doi: 10.2196/64186.PMID: 40112293 Free article.

 

  1. Utility-based Analysis of Statistical Approaches and Deep Learning Models for Synthetic Data Generation With Focus on Correlation Structures: Algorithm Development and Validation. Miletic M, Sariyar M.JMIR AI. 2025 Mar 20;4:e65729. doi: 10.2196/65729.PMID: 40112290 Free article.

 

  1. EEC-GIFT: a fairness-aware machine learning framework for lung cancer screening eligibility using real-world data. Conahan P, Robinson LA, Le T, Valdes G, Schabath MB, Byrne MM, Green L, El Naqa I, Luo Y.JNCI Cancer Spectr. 2025 Mar 20:pkaf030. doi: 10.1093/jncics/pkaf030. Online ahead of print.PMID: 40111867

 

  1. CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A Podcast. de Lima M, Marks DI.Target Oncol. 2025 Mar 20. doi: 10.1007/s11523-025-01129-5. Online ahead of print.PMID: 40111710

 

  1. Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma. Ng SC, Moon JH, Park SS, Koh Y, Lee JH, Eom HS, Shin HJ, Jung SH, Do YR, Wilfred G, Husin A, Kim HJ, Abdul Wahid S, Lee MW, Heo HW, Kim K, Chuncharunee S.Int J Hematol. 2025 Mar 20. doi: 10.1007/s12185-025-03927-z. Online ahead of print.PMID: 40111640

 

  1. Sex-specific outcomes in myocardial infarction: a dual-cohort analysis using clinical and real-world data. Krefting J, Graesser C, Novacek S, Voll F, Moggio A, Krueger N, Friess C, Schwab M, Offenborn F, Trenkwalder T, Kufner S, Xhepa E, Joner M, Cassese S, Schunkert H, Ndrepepa G, Kastrati A, von Scheidt M, Kessler T, Sager HB.Clin Res Cardiol. 2025 Mar 20. doi: 10.1007/s00392-025-02627-2. Online ahead of print.PMID: 40111442

 

  1. 25 years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children. Carbonell-Estrany X, Simões EAF, Bont L, Manzoni P, Zar HJ, Greenough A, Ramilo O, Stein R, Law B, Mejias A, Sanchez Luna M, Checchia PA, Krilov L, Lanari M, Dagan R, Fauroux B, Resch B, Heikkinen T, Domachowske JB, Wildenbeest JG, Martinon-Torres F, Thwaites R, Cetinkaya M, Alharbi AS, Rodriguez-Martinez CE, Noyola DE, Kassim A, Kusuda S, Kang JM, Rodgers-Gray B, Platonova A, Jah F, Paes B.Expert Rev Anti Infect Ther. 2025 Mar 20. doi: 10.1080/14787210.2025.2481908. Online ahead of print.PMID: 40111069 Review.

 

  1. Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care. Gillmore JD, Hahn K, Smith JG, Conceição I, Tian Z, Grogan M, Pao C, Wittbrodt E, Järbrink K, Papas MA, Davis MK.Cardiol Ther. 2025 Mar 19. doi: 10.1007/s40119-025-00402-y. Online ahead of print.PMID: 40108078

 

  1. The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. Zanframundo G, Dourado E, Bauer-Ventura I, Faghihi-Kashani S, Yoshida A, Loganathan A, Rivero-Gallegos D, Lim D, Bozán F, Sambataro G, Bae SS, Yamano Y, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Montecucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Selva-O'Callaghan A, Werth VP, Hansen P, Rozza D, Scirè CA, Sakellariou G, Kaneko Y, Triantafyllias K, Castañeda S, Alberti ML, Merino MGG, Fiehn C, Molad Y, Govoni M, Nakashima R, Alpsoy E, Giannini M, Chinoy H, Gallay L, Ebstein E, Campagne J, Saraiva AP, Conticini E, Sebastiani GD, Nuño-Nuño L, Scarpato S, Schiopu E, Parker M, Limonta M; CLASS project participating investigators; Cavagna L, Aggarwal R. Ann Rheum Dis. 2025 Mar 18:S0003-4967(25)00204-3. doi: 10.1016/j.ard.2025.01.050. Online ahead of print.PMID: 40107904

 

  1. Comparative analysis of CDKI-related adverse events in older patients: a real-world data from the FDA adverse event reporting system database. Fang Q, Huang F, Zhao H, Liang J, Chen Y, Wu X, Zhang M, Luo W.Expert Opin Drug Saf. 2025 Mar 21:1-10. doi: 10.1080/14740338.2025.2464113. Online ahead of print.PMID: 40107713

 

  1. Real-world data on behavioral practices for dogs in primary care veterinary hospitals in the United States (2010-2020). Weng HY, Morrison JA, Topdjian K, Ogata N.J Am Vet Med Assoc. 2025 Mar 19:1-7. doi: 10.2460/javma.24.06.0412. Online ahead of print.PMID: 40107234

 

  1. It is never too late to stop smoking. Applying working estimates of smoking cessation on five-year overall survival gains after a cancer diagnosis. El-Haddad N, Li Y, Delaney GP, Kang H, Vinod S, Barr M, Tabuchi T, Kidd M, Sitas F.Cancer Epidemiol. 2025 Mar 18;96:102775. doi: 10.1016/j.canep.2025.102775. Online ahead of print.PMID: 40106868

 

  1. Machine Learning-Based Explainable Automated Nonlinear Computation Scoring System for Health Score and an Application for Prediction of Perioperative Stroke: Retrospective Study. Oh MY, Kim HS, Jung YM, Lee HC, Lee SB, Lee SM.J Med Internet Res. 2025 Mar 19;27:e58021. doi: 10.2196/58021.PMID: 40106818 Free article.

 

  1. Leveraging social media data to study disease and treatment characteristics of Hodgkin's lymphoma Using Natural Language Processing methods. Siddiqui ZA, Pathan M, Nduaguba S, LeMasters T, Scott VG, Sambamoorthi U, Patel JS.PLOS Digit Health. 2025 Mar 19;4(3):e0000765. doi: 10.1371/journal.pdig.0000765. eCollection 2025 Mar.PMID: 40106471 Free PMC article.

 

  1. A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study. Molero P, Ibañez A, de Diego-Adeliño J, Ramos-Quiroga JA, García Dorado M, López Rengel PM, Saiz PA.Adv Ther. 2025 Mar 19. doi: 10.1007/s12325-025-03149-z. Online ahead of print.PMID: 40106175

 

  1. Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer: A Target Trial Emulation Using Nationwide Swedish Registry Data. Lampa E, Boros M, Berglund A, Wagenius G, Oskarsdottir GN.Ann Surg Oncol. 2025 Mar 19. doi: 10.1245/s10434-025-17193-0. Online ahead of print.PMID: 40106109

 

  1. Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinoma. Haack M, Neuberger S, Boerner JH, Ziewers S, Duwe G, Dotzauer R, Haferkamp A, Mager R.Discov Oncol. 2025 Mar 19;16(1):359. doi: 10.1007/s12672-025-02131-z.PMID: 40106049 Free PMC article.

 

  1. Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. Castro E, Orji C, Ribbands A, Butcher J, Walley M, Li W, Ghate SR.Future Oncol. 2025 Mar 19:1-15. doi: 10.1080/14796694.2025.2470616. Online ahead of print.PMID: 40105456

 

  1. Meningococcal vaccination disparities in the United States (2010-2021): Findings from the National Immunization Survey-Teen and a commercial insurance database. Herrera-Restrepo O, Kwiatkowska M, Huse S, Ndegwa N, Kocaata Z, Ganz ML. Hum Vaccin Immunother. 2025 Dec;21(1):2479338. doi: 10.1080/21645515.2025.2479338. Epub 2025 Mar 19.PMID: 40105019 Free article.

 

  1. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. 2025 Mar 19. doi: 10.1111/add.70040. Online ahead of print.PMID: 40104887

 

  1. Treating class 2-3 obesity with glucagon-like peptide-1 agonists: A 2-year real-world cohort study. Abdel-Bary M, Brody A, Schmitt J, Prieto K, Wetzel A, Juo YY.Diabetes Obes Metab. 2025 Mar 19. doi: 10.1111/dom.16331. Online ahead of print.PMID: 40104874

 

  1. Determinant-based grouping of SNPs and its application for detecting disease-associated genomic loci. Khvorykh G, Khrunin A.NAR Genom Bioinform. 2025 Mar 18;7(1):lqaf024. doi: 10.1093/nargab/lqaf024. eCollection 2025 Mar.PMID: 40104675 Free PMC article.

 

  1. The importance of getting the dose right in the treatment of tuberculosis. Dudnyk A, Lutchmun W, Duarte R, Lange C, Svensson EM.Breathe (Sheff). 2025 Mar 18;21(1):240177. doi: 10.1183/20734735.0177-2024. eCollection 2025 Jan.PMID: 40104255 Free PMC article.

 

  1. Enhancing malignant transformation predictions in oral potentially malignant disorders: A novel machine learning framework using real-worlddata. Li JW, Zhang MJ, Zhou YF, Adeoye J, Pu JYJ, Thomson P, McGrath CP, Zhang D, Zheng LW. 2025 Feb 18;28(3):112062. doi: 10.1016/j.isci.2025.112062. eCollection 2025 Mar 21.PMID: 40104065 Free PMC article.

 

  1. Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial.
  2. Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M. 2025 Mar 18;9(3):e70101. doi: 10.1002/hem3.70101. eCollection 2025 Mar.PMID: 40104044 Free PMC article.

 

  1. Bayesian Growth Curve Modeling with Measurement Error in Time. Zhang L, Qu W, Zhang Z.Multivariate Behav Res. 2025 Mar 19:1-19. doi: 10.1080/00273171.2025.2473937. Online ahead of print.PMID: 40103564

 

  1. Real-world insights of patient voices with age-related macular degeneration in the Republic of Korea and Taiwan: an AI-based Digital Listening study by Semantic-Natural Language Processing. Jeon H, Yu SY, Chertkova O, Yun H, Ng YL, Lim YY, Efimenko I, Makhlouf DM.BMC Med Inform Decis Mak. 2025 Mar 18;25(1):137. doi: 10.1186/s12911-025-02929-5.PMID: 40102785 Free PMC article.

 

  1. Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals. Sledge GW Jr, Yoshino T, Xiu J, Helmstetter A, Ribeiro JR, Klimov S, Gilg B, Gao JJ, Elton J, Oberley MJ, Radovich M, Abraham J, Spetzler D.Nat Commun. 2025 Mar 18;16(1):2646. doi: 10.1038/s41467-025-57941-0.PMID: 40102447 Free PMC article.

 

  1. Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE Generation. Gatto NM, Garry EM, Wang M, Zariffa N, Roe L, Chakravarty A, Rivera D.Ther Innov Regul Sci. 2025 Mar 18. doi: 10.1007/s43441-025-00748-4. Online ahead of print.PMID: 40102361

 

  1. Real-world evidence for regulatory purposes: The example of DARWIN EU. Raventos B, Prieto-Alhambra D.Farm Hosp. 2025 Mar 17:S1130-6343(25)00018-2. doi: 10.1016/j.farma.2025.02.011. Online ahead of print.PMID: 40102084 Free article. English, Spanish. No abstract available.

 

  1. Gastroenteritis hospitalizations over 19 years before and after introduction of rotavirus vaccine in Japan: A nationwide claims database. Yanai T, Yoshida S, Kawakami K. 2025 Mar 17;55:127027. doi: 10.1016/j.vaccine.2025.127027. Online ahead of print.PMID: 40101324

 

  1. Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter? Dalgetty M, Cortes J. 2025 Mar 18:blood.2024027944. doi: 10.1182/blood.2024027944. Online ahead of print.PMID: 40101136

 

  1. Brodalumab for Plaque Psoriasis in the Canadian Real-World Setting: A Retrospective Cohort Analysis of up to 4 Years. Gaudet V, Turchin I, Lynde CW, Kelly V, Sajic D, Hassan S, Yap B, Barakat M, Prajapati VH.Dermatol Ther (Heidelb). 2025 Mar 18. doi: 10.1007/s13555-025-01369-3. Online ahead of print.PMID: 40100536

 

  1. Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa. Dahir KM, Dunbar NS.Curr Osteoporos Rep. 2025 Mar 18;23(1):14. doi: 10.1007/s11914-025-00906-5.PMID: 40100438 Free PMC article.

 

  1. Long-term effects of continuous glucose monitoring on glycaemic control: Real-world evidence in a general adult population with type 1 diabetes in Norway. Åsvold BO, Skarø M, Valle C, Grytli B, Fougner SL.Diabetes Obes Metab. 2025 Mar 18. doi: 10.1111/dom.16334. Online ahead of print.PMID: 40099648 No abstract available.

 

  1. Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable. Alsina M, Dhakal B, Pantin J, Huff CA, Janakiram M.Future Oncol. 2025 Mar 18:1-8. doi: 10.1080/14796694.2025.2476382. Online ahead of print.PMID: 40098471

 

  1. Twenty Years of Experience in One Thousand De-Novo Left Main Coronary Angioplasty With Angiographic Control in a High-Volume Centre Without On-Site Cardiac Surgery. Franzé A, Zecchino S, Tomassini F, Rolfo C, Cerrato E, Pavani M, Piedimonte G, Zanda G, Di Fonzo R, Massino M, Lococo M, Celentani D, Migliardi A, Gnavi R, Chinaglia A, Varbella F.Catheter Cardiovasc Interv. 2025 Mar 18. doi: 10.1002/ccd.31488. Online ahead of print.PMID: 40098435

 

  1. Adverse Reactions to Ginkgo biloba Medicinal Products Released in European Countries. Ammendolia I, Attard E, Mannucci C, Esposito E, Calapai G, Currò M, Midiri P, Attard T, Cardia L, Calapai F. Phytother Res. 2025 Mar 18. doi: 10.1002/ptr.8475. Online ahead of print.PMID: 40098412 No abstract available.

 

  1. A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS). Xue Z, Liu X, Liu Q, Yang X, Yu L.BMC Pharmacol Toxicol. 2025 Mar 17;26(1):63. doi: 10.1186/s40360-025-00890-7.PMID: 40098168 Free PMC article.

 

  1. The impact of maternal HBeAg carries status and elevated ALT values on adverse outcomes: a population-based cohort study in 198,049 pregnancies. Zou K, Huang S, Liu C, Zhao P, Guo J, Wei W, Chen J, Yao G, Qian Y, Rong B, Chen M, Xiong Y, Sun X, Tan J.BMC Pregnancy Childbirth. 2025 Mar 17;25(1):302. doi: 10.1186/s12884-025-07410-9.PMID: 40097956 Free PMC article.

 

  1. Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China. Zhang J, Wang G, Xie X, Pan W, Dong Q, Zhang N, Dong J, Zhou L, Zhou C, Li J, Segall G, Zhang Y.Future Oncol. 2025 Mar 17:1-10. doi: 10.1080/14796694.2025.2476930. Online ahead of print.PMID: 40091795

 

  1. Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea. Kim KM, Choi JH, Han B, Hur YI, Son JW, Nam GE, Kang JH, Cho YJ, Kim WJ, Lim S.Diabetes Obes Metab. 2025 Mar 17. doi: 10.1111/dom.16342. Online ahead of print.PMID: 40091462

 

  1. Neoadjuvant treatment with immune checkpoint inhibitors in patients with melanoma: A real-life retrospective study. Tomsitz D, Zimmermann P, Kunz WG, Neumann J, Siegmund BJ, Weiss BG, Kauke T, Sienel W, French LE, Klauschen F, Heinzerling L.J Dtsch Dermatol Ges. 2025 Mar 17. doi: 10.1111/ddg.15632. Online ahead of print.PMID: 40091460

 

  1. Cancer publications using real-world data from the Taiwan National Health Insurance Research Database: conceptual framework and bibliometric analysis. Siu WHS, Lim AY, Liu JR, Chang SH, Chen WM, Li PR, See LC.J Chin Med Assoc. 2025 Mar 17. doi: 10.1097/JCMA.0000000000001227. Online ahead of print.PMID: 40090935

 

  1. Harnessing Electronic Health Records and Artificial Intelligence for Enhanced Cardiovascular Risk Prediction: A Comprehensive Review. Tsai ML, Chen KF, Chen PC.J Am Heart Assoc. 2025 Mar 18;14(6):e036946. doi: 10.1161/JAHA.124.036946. Epub 2025 Mar 13.PMID: 40079336 Free article.

 

  1. Belimumab patient profile in Spain: evolution during the last decade and future directions. Salman-Monte TC, Cuadrado MJ, Galindo M, Espinosa G, Morales E, Pego-Reigosa JM, Pallarés L, López C, San Román C, Rúa-Figueroa Í.Expert Opin Biol Ther. 2025 Mar 20:1-11. doi: 10.1080/14712598.2025.2479018. Online ahead of print.PMID: 40077897 Review.

 

  1. Hospital medical device quality and safety monitoring using real-world data from Friuli Venezia Giulia regional health coordination agency. Flamigni A, Trojniak MP, Distefano L, Mattioni L, Cupo D, Zanier M, Arbo A.Expert Rev Med Devices. 2025 Mar 17:1-9. doi: 10.1080/17434440.2025.2475242.

 

  1. Multi-Scale and Multi-Level Feature Assessment Framework for Classification of Parkinson's Disease State From Short-Term Motor Tasks. Peng X, Zhao Y, Li Z, Wang X, Nan F, Zhao Z, Yang Y, Yang P.IEEE Trans Biomed Eng. 2025 Apr;72(4):1211-1224. doi: 10.1109/TBME.2024.3418688. Epub 2025 Mar 20.PMID: 40036439